These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8593385)

  • 21. Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India.
    Tubercle; 1983 Jun; 64(2):73-91. PubMed ID: 6351390
    [No Abstract]   [Full Text] [Related]  

  • 22. [Controversy over tuberculosis therapy in HIV infected patients. Isoniazide therapy--brief chemotherapy].
    Arnheim K
    Fortschr Med; 1995 Dec; 113(35-36):14-5. PubMed ID: 8582689
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection.
    Levine B; Chaisson RE
    Ann Intern Med; 1991 May; 114(10):861-8. PubMed ID: 1673053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of pulmonary infection with mycobacterium xenopi].
    Kawamura M; Kusanagi Y; Satou Y; Itou S; Honma M; Shimoide H
    Nihon Kokyuki Gakkai Zasshi; 1998 Jan; 36(1):86-9. PubMed ID: 9611983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Isoniazid pharmacokinetics in the combined chemotherapy of tuberculosis].
    Sokolova GB; Vilenskaia RN; Ivleva AIa; Galenko NN; Ziia AV
    Probl Tuberk; 1981 Oct; (10):24-8. PubMed ID: 7312844
    [No Abstract]   [Full Text] [Related]  

  • 26. Pulmonary infection due to Mycobacterium szulgai.
    Sánchez-Alarcos JM; De Miguel-Díez J; Bonilla I; Sicilia JJ; Alvarez-Sala JL
    Respiration; 2003; 70(5):533-6. PubMed ID: 14665782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cavitary lung infection caused by Mycobacterium flavescens.
    Casimir MT; Fainstein V; Papadopolous N
    South Med J; 1982 Feb; 75(2):253-4. PubMed ID: 7058379
    [No Abstract]   [Full Text] [Related]  

  • 28. The microbiology, chemotherapy, and surgical treatment of tuberculosis.
    Boyars MC
    J Thorac Imaging; 1990 Apr; 5(2):1-7. PubMed ID: 2182899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New aspects of chemotherapy of tuberculosis].
    Khomenko AG
    Probl Tuberk; 1980 Jul; (7):14-9. PubMed ID: 7413630
    [No Abstract]   [Full Text] [Related]  

  • 30. [Preliminary results of rifabutine (ansamycine LM 427) treatment of patients with newly detected and chronic pulmonary tuberculosis and Mycobacterium infections].
    Rowińska-Zakrzewska E; Słupek A; Graczyk J; Zwolska-Kwiek Z; Augustynowicz-Kopeć E; Stambrowska A; Byszewska D; Latoś E; Pilarska A; Andrzejczyk Z
    Pneumonol Alergol Pol; 1992; 60(9-10):81-8. PubMed ID: 1338003
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of intensive chemotherapy on bacterial excretion in fibrocavernous pulmonary tuberculosis].
    Bondarev IM; Sagalovich VIa; Kanevskaia SS; Sharapova VI
    Probl Tuberk; 1979 May; (5):16-21. PubMed ID: 471989
    [No Abstract]   [Full Text] [Related]  

  • 32. Pulmonary Infection Caused by Mycobacterium shinjukuense.
    Oshima K; Yokouchi H; Minemura H; Saito J; Tanino Y; Munakata M
    Ann Am Thorac Soc; 2015 Jun; 12(6):958-9. PubMed ID: 26075560
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.
    Al Jarad N; Demertzis P; Jones DJ; Barnes NC; Rudd RM; Gaya H; Wedzicha JA; Hughes DT; Empey DW
    Thorax; 1996 Feb; 51(2):137-9. PubMed ID: 8711643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intermittent chemotherapy of pulmonary tuberculosis (review of the literature)].
    Utkin VV
    Probl Tuberk; 1978 Oct; (10):23-8. PubMed ID: 714901
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis.
    Koh WJ; Kwon OJ; Park YK; Lew WJ; Bai GH
    Eur Respir J; 2005 Sep; 26(3):557. PubMed ID: 16135740
    [No Abstract]   [Full Text] [Related]  

  • 36. [Intensive chemotherapy of pulmonary tuberculosis].
    Shesterina MV; Gavrilenko VS; Tarasova EF; Sokolova GV; Tregubov IuG
    Probl Tuberk; 1980 Jul; (7):20-22. PubMed ID: 6997865
    [No Abstract]   [Full Text] [Related]  

  • 37. Rifampin-resistant Mycobacterium kansasii.
    Wallace RJ; Dunbar D; Brown BA; Onyi G; Dunlap R; Ahn CH; Murphy DT
    Clin Infect Dis; 1994 May; 18(5):736-43. PubMed ID: 8075262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 39. Rapid improvement of Mycobacterium kansasii pneumonia after rifabutin, isoniazid, and ethambutol: A case report.
    Kuo HI; Huang ST; Wu YH
    Kaohsiung J Med Sci; 2022 Nov; 38(11):1137-1138. PubMed ID: 36254860
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antituberculosis chemotherapy including ofloxacin in patients with pulmonary tuberculosis not treated previously].
    Tsukamura M; Yoshii S; Yasuda Y; Saito H
    Kekkaku; 1986 Jan; 61(1):15-7. PubMed ID: 3458966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.